×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Balance Sheet

Balance Sheet

  Year Ending Dec 2018 (Update) Year Ending Dec 2017 (Update) Year Ending Dec 2016 (Update) Year Ending Dec 2015 (Restated)
Cash & Equivalents 6,945.00 3,800.00 3,241.00 4,144.00
Short Term Investments 22,359.00 37,878.00 34,844.00 27,238.00
Cash and Short Term Investments 29,304.00 41,678.00 38,085.00 31,382.00
Accounts Receivable - Trade, Gross 0.00 0.00 0.00 0.00
Provision for Doubtful Accounts 0.00 0.00 0.00 0.00
Accounts Receivable - Trade, Net 3,580.00 3,237.00 3,165.00 2,995.00
Total Receivables, Net 3,580.00 3,237.00 3,165.00 2,995.00
Inventories - Finished Goods 1,023.00 934.00 912.00 705.00
Inventories - Work In Progress 1,660.00 1,668.00 1,608.00 1,529.00
Inventories - Raw Materials 257.00 232.00 225.00 201.00
Total Inventory 2,940.00 2,834.00 2,745.00 2,435.00
Other Current Assets 1,794.00 1,727.00 2,015.00 1,703.00
Other Current Assets, Total 1,794.00 1,727.00 2,015.00 1,703.00
Total Current Assets 37,618.00 49,476.00 46,010.00 38,515.00
Buildings - Gross 3,616.00 3,507.00 3,640.00 0.00
Land/Improvements - Gross 265.00 283.00 295.00 0.00
Machinery/Equipment - Gross 4,716.00 3,551.00 3,367.00 0.00
Construction in Progress - Gross 953.00 834.00 745.00 0.00
Other Property/Plant/Equipment - Gross 3,204.00 4,404.00 4,380.00 0.00
Property/Plant/Equipment, Total - Gross 12,754.00 12,579.00 12,427.00 0.00
Accumulated Depreciation, Total -7,796.00 -7,590.00 -7,466.00 0.00
Property/Plant/Equipment, Total - Net 4,958.00 4,989.00 4,961.00 4,907.00
Goodwill, Net 14,699.00 14,761.00 14,751.00 14,787.00
Intangibles - Gross 18,845.00 18,730.00 19,023.00 18,920.00
Accumulated Intangible Amortization -11,402.00 -10,121.00 -8,744.00 -7,279.00
Intangibles, Net 7,443.00 8,609.00 10,279.00 11,641.00
LT Investment - Affiliate Companies 0.00 570.00 501.00 0.00
LT Investments - Other 0.00 0.00 0.00 0.00
Long Term Investments 0.00 570.00 501.00 0.00
Other Long Term Assets 1,698.00 1,549.00 1,124.00 1,599.00
Other Long Term Assets, Total 1,698.00 1,549.00 1,124.00 1,599.00
Total Assets 66,416.00 79,954.00 77,626.00 71,449.00
Accounts Payable 1,207.00 1,352.00 917.00 965.00
Accrued Expenses 6,948.00 5,563.00 4,964.00 5,451.00
Notes Payable/Short Term Debt 0.00 0.00 0.00 0.00
Current Portion of Long Term Debt/Capital Leases 4,419.00 1,152.00 4,403.00 2,247.00
Dividends Payable 914.00 953.00 920.00 0.00
Other Current Liabilities 0.00 0.00 0.00 1.00
Other Current liabilities, Total 914.00 953.00 920.00 1.00
Total Current Liabilities 13,488.00 9,020.00 11,204.00 8,664.00
Long Term Debt 29,510.00 34,190.00 30,193.00 29,182.00
Total Long Term Debt 29,510.00 34,190.00 30,193.00 29,182.00
Total Debt 33,929.00 35,342.00 34,596.00 31,429.00
Deferred Income Tax - Long Term Liability 864.00 1,166.00 2,436.00 2,239.00
Deferred Income Tax 864.00 1,166.00 2,436.00 2,239.00
Other Long Term Liabilities 10,054.00 10,337.00 3,918.00 3,281.00
Other Liabilities, Total 10,054.00 10,337.00 3,918.00 3,281.00
Total Liabilities 53,916.00 54,713.00 47,751.00 43,366.00
Common Stock 31,246.00 30,992.00 30,784.00 30,649.00
Common Stock, Total 31,246.00 30,992.00 30,784.00 30,649.00
Retained Earnings (Accumulated Deficit) -17,977.00 -5,072.00 -438.00 -2,086.00
Unrealized Gain (Loss) -338.00 -144.00 -138.00 -260.00
Cumulative Translation Adjustment -670.00 -529.00 -610.00 -511.00
Other Comprehensive Income 239.00 -6.00 277.00 291.00
Other Equity, Total -431.00 -535.00 -333.00 -220.00
Total Equity 12,500.00 25,241.00 29,875.00 28,083.00
Total Liabilities & Shareholders' Equity 66,416.00 79,954.00 77,626.00 71,449.00
Shares Outstanding – Common Stock Primary Issue 629.60 722.20 738.20 751.30
Total Common Shares Outstanding 629.60 722.20 738.20 751.30
Treasury Shares – Common Primary Issue 0.00 0.00 0.00 0.00
Employees 21,500.00 20,800.00 19,200.00 17,900.00
Part-Time Employees 0.00 0.00 0.00 0.00
Number of Common Shareholders 5,760.00 6,070.00 6,444.00 6,809.00
Accumulated Intangible Amortization 11,402.00 10,121.00 8,744.00 7,279.00
Total Current Assets less Inventory 34,678.00 46,642.00 43,265.00 36,080.00
Quick Ratio 2.57 5.17 3.86 4.16
Current Ratio 2.79 5.49 4.11 4.45
Net Debt 4,625.00 -6,336.00 -3,489.00 47.00
Tangible Book Value -9,642.00 1,871.00 4,845.00 1,655.00
Tangible Book Value per Share -15.31 2.59 6.56 2.20
Total Long Term Debt, Supplemental 34,878.00 36,271.00 35,532.00 0.00
Long Term Debt Maturing within 1 Year 4,424.00 1,153.00 4,405.00 0.00
Long Term Debt Maturing in Year 2 2,950.00 4,460.00 1,076.00 0.00
Long Term Debt Maturing in Year 3 3,500.00 2,950.00 3,360.00 0.00
Long Term Debt Maturing in Year 4 4,183.00 3,500.00 1,950.00 0.00
Long Term Debt Maturing in Year 5 1,463.00 4,251.00 3,500.00 0.00
Long Term Debt Maturing in 2-3 Years 6,450.00 7,410.00 4,436.00 0.00
Long Term Debt Maturing in 4-5 Years 5,646.00 7,751.00 5,450.00 0.00
Long Term Debt Maturing in Year 6 & Beyond 18,358.00 19,957.00 21,241.00 0.00
Total Operating Leases 569.00 650.00 787.00 0.00
Operating Lease Payments Due in Year 1 164.00 158.00 156.00 0.00
Operating Lease Payments Due in Year 2 126.00 126.00 149.00 0.00
Operating Lease Payments Due in Year 3 113.00 116.00 135.00 0.00
Operating Lease Payments Due in Year 4 64.00 100.00 123.00 0.00
Operating Lease Payments Due in Year 5 56.00 59.00 108.00 0.00
Operating Lease Payments Due in 2-3 Years 239.00 242.00 284.00 0.00
Operating Lease Payments Due in 4-5 Years 120.00 159.00 231.00 0.00
Standardized Operating Lease Payments Due in Year 6 and Beyond 46.00 91.00 116.00 0.00
Number of Patents 0.00 0.00 10.00 9.00
Number of Products in Phase I 22.00 17.00 14.00 13.00
Number of Products in Phase II 3.00 5.00 5.00 8.00
Number of Products in Phase III 7.00 11.00 12.00 12.00
Number of Products in Pre-Registration 0.00 0.00 0.00 0.00
Number of Products Launched 0.00 0.00 0.00 0.00
For a more complete picture of our financial results, please review our SEC Filings

Copyright Thomson Reuters Corporation